View in EDS

Combination anti-PD-1 and antiretroviral therapy provides therapeutic benefit against SIV.

Saved in:
Bibliographic Details
Title: Combination anti-PD-1 and antiretroviral therapy provides therapeutic benefit against SIV.
Authors: Mylvaganam GH; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA.; Division of Microbiology and Immunology, Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA., Chea LS; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA.; Division of Microbiology and Immunology, Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA., Tharp GK; Division of Microbiology and Immunology, Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA., Hicks S; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA.; Division of Microbiology and Immunology, Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA., Velu V; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA.; Division of Microbiology and Immunology, Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA., Iyer SS; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA.; Division of Microbiology and Immunology, Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA., Deleage C; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland, USA., Estes JD; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland, USA., Bosinger SE; Division of Microbiology and Immunology, Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA., Freeman GJ; Department of Medical Oncology and Cancer Vaccine Center, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Ahmed R; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA.; Division of Microbiology and Immunology, Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA., Amara RR; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA.; Division of Microbiology and Immunology, Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Source: JCI insight [JCI Insight] 2018 Sep 20; Vol. 3 (18). Date of Electronic Publication: 2018 Sep 20 (Print Publication: 2018).
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model: eCollection Cited Medium: Internet ISSN: 2379-3708 (Electronic) Linking ISSN: 23793708 NLM ISO Abbreviation: JCI Insight Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 30232277
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Combination anti-PD-1 and antiretroviral therapy provides therapeutic benefit against SIV.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mylvaganam+GH%22">Mylvaganam GH</searchLink>; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA.; Division of Microbiology and Immunology, Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Chea+LS%22">Chea LS</searchLink>; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA.; Division of Microbiology and Immunology, Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Tharp+GK%22">Tharp GK</searchLink>; Division of Microbiology and Immunology, Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Hicks+S%22">Hicks S</searchLink>; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA.; Division of Microbiology and Immunology, Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Velu+V%22">Velu V</searchLink>; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA.; Division of Microbiology and Immunology, Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Iyer+SS%22">Iyer SS</searchLink>; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA.; Division of Microbiology and Immunology, Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Deleage+C%22">Deleage C</searchLink>; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Estes+JD%22">Estes JD</searchLink>; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Bosinger+SE%22">Bosinger SE</searchLink>; Division of Microbiology and Immunology, Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Freeman+GJ%22">Freeman GJ</searchLink>; Department of Medical Oncology and Cancer Vaccine Center, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Ahmed+R%22">Ahmed R</searchLink>; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA.; Division of Microbiology and Immunology, Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Amara+RR%22">Amara RR</searchLink>; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA.; Division of Microbiology and Immunology, Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101676073%22">JCI insight</searchLink> [JCI Insight] 2018 Sep 20; Vol. 3 (18). <i>Date of Electronic Publication: </i>2018 Sep 20 (<i>Print Publication: </i>2018).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+for+Clinical+Investigation%22">American Society for Clinical Investigation </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101676073 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2379-3708 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223793708%22">23793708 </searchLink><i>NLM ISO Abbreviation: </i>JCI Insight <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30232277
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1172/jci.insight.122940
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Combination anti-PD-1 and antiretroviral therapy provides therapeutic benefit against SIV.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mylvaganam GH
      – PersonEntity:
          Name:
            NameFull: Chea LS
      – PersonEntity:
          Name:
            NameFull: Tharp GK
      – PersonEntity:
          Name:
            NameFull: Hicks S
      – PersonEntity:
          Name:
            NameFull: Velu V
      – PersonEntity:
          Name:
            NameFull: Iyer SS
      – PersonEntity:
          Name:
            NameFull: Deleage C
      – PersonEntity:
          Name:
            NameFull: Estes JD
      – PersonEntity:
          Name:
            NameFull: Bosinger SE
      – PersonEntity:
          Name:
            NameFull: Freeman GJ
      – PersonEntity:
          Name:
            NameFull: Ahmed R
      – PersonEntity:
          Name:
            NameFull: Amara RR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 20
              M: 09
              Text: 2018 Sep 20
              Type: published
              Y: 2018
          Identifiers:
            – Type: issn-electronic
              Value: 2379-3708
          Numbering:
            – Type: volume
              Value: 3
            – Type: issue
              Value: 18
          Titles:
            – TitleFull: JCI insight
              Type: main
ResultId 1